These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15912043)

  • 1. Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal cancer.
    Heslin MJ; Hawkins A; Boedefeld W; Arnoletti JP; Frolov A; Soong R; Urist MM; Bland KI
    Ann Surg; 2005 Jun; 241(6):941-6; discussion 946-7. PubMed ID: 15912043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells.
    Shureiqi I; Chen D; Lee JJ; Yang P; Newman RA; Brenner DE; Lotan R; Fischer SM; Lippman SM
    J Natl Cancer Inst; 2000 Jul; 92(14):1136-42. PubMed ID: 10904086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis.
    Shureiqi I; Wu Y; Chen D; Yang XL; Guan B; Morris JS; Yang P; Newman RA; Broaddus R; Hamilton SR; Lynch P; Levin B; Fischer SM; Lippman SM
    Cancer Res; 2005 Dec; 65(24):11486-92. PubMed ID: 16357157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells.
    Shureiqi I; Jiang W; Zuo X; Wu Y; Stimmel JB; Leesnitzer LM; Morris JS; Fan HZ; Fischer SM; Lippman SM
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9968-73. PubMed ID: 12909723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells.
    Cianchi F; Cortesini C; Magnelli L; Fanti E; Papucci L; Schiavone N; Messerini L; Vannacci A; Capaccioli S; Perna F; Lulli M; Fabbroni V; Perigli G; Bechi P; Masini E
    Mol Cancer Ther; 2006 Nov; 5(11):2716-26. PubMed ID: 17121918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15-Lipoxygenase-1 mediates cyclooxygenase-2 inhibitor-induced apoptosis in gastric cancer.
    Wu J; Xia HH; Tu SP; Fan DM; Lin MC; Kung HF; Lam SK; Wong BC
    Carcinogenesis; 2003 Feb; 24(2):243-7. PubMed ID: 12584173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression.
    Shureiqi I; Xu X; Chen D; Lotan R; Morris JS; Fischer SM; Lippman SM
    Cancer Res; 2001 Jun; 61(12):4879-84. PubMed ID: 11406566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma.
    Tuynman JB; Buskens CJ; Kemper K; ten Kate FJ; Offerhaus GJ; Richel DJ; van Lanschot JJ
    Ann Surg; 2005 Dec; 242(6):840-9, discussion 849-50. PubMed ID: 16327494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib.
    Li N; Sood S; Wang S; Fang M; Wang P; Sun Z; Yang CS; Chen X
    Clin Cancer Res; 2005 Mar; 11(5):2089-96. PubMed ID: 15756036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.
    Sinicrope FA; Half E; Morris JS; Lynch PM; Morrow JD; Levin B; Hawk ET; Cohen DS; Ayers GD; Stephens LC;
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):920-7. PubMed ID: 15184247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eicosanoid metabolism in squamous cell carcinoma cell lines derived from primary and metastatic head and neck cancer and its modulation by celecoxib.
    Schroeder CP; Yang P; Newman RA; Lotan R
    Cancer Biol Ther; 2004 Sep; 3(9):847-52. PubMed ID: 15254428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers.
    Shureiqi I; Wojno KJ; Poore JA; Reddy RG; Moussalli MJ; Spindler SA; Greenson JK; Normolle D; Hasan AA; Lawrence TS; Brenner DE
    Carcinogenesis; 1999 Oct; 20(10):1985-95. PubMed ID: 10506115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular FLICE-inhibitory protein down-regulation contributes to celecoxib-induced apoptosis in human lung cancer cells.
    Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
    Cancer Res; 2006 Dec; 66(23):11115-9. PubMed ID: 17145853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals.
    Liu SH; Shen CC; Yi YC; Tsai JJ; Wang CC; Chueh JT; Lin KL; Lee TC; Pan HC; Sheu ML
    Br J Pharmacol; 2010 Aug; 160(8):1963-72. PubMed ID: 20649594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA-6 transcriptional regulation of 15-lipoxygenase-1 during NSAID-induced apoptosis in colorectal cancer cells.
    Shureiqi I; Jiang W; Fischer SM; Xu X; Chen D; Lee JJ; Lotan R; Lippman SM
    Cancer Res; 2002 Feb; 62(4):1178-83. PubMed ID: 11861401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.
    Liu X; Yue P; Zhou Z; Khuri FR; Sun SY
    J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 12/15 Lipoxygenase regulation of colorectal tumorigenesis is determined by the relative tumor levels of its metabolite 12-HETE and 13-HODE in animal models.
    Chang J; Jiang L; Wang Y; Yao B; Yang S; Zhang B; Zhang MZ
    Oncotarget; 2015 Feb; 6(5):2879-88. PubMed ID: 25576922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of 15-lipoxygenase-1 in human colorectal cancer.
    Ikawa H; Kamitani H; Calvo BF; Foley JF; Eling TE
    Cancer Res; 1999 Jan; 59(2):360-6. PubMed ID: 9927047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinicopathological significance of REIC expression in colorectal carcinomas.
    Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
    Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.